Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.
Long before a liver tumor appears, a high-fat diet can push liver cells into a risky survival mode. That is the central ...
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a ...
If you’ve wondered what a preamplifier is, what it exactly does, and whether your audio setup is missing one, we’ve got the ...
Before talking about Micro RGB, let’s look at color space and gamut both for HDR, which uses the BT.2020 standard, and SDR, ...
The year has been full of scary details about the tiny particles. Here’s what we know now.
Today at CES, Intel said laptop preorders will begin tomorrow, January 6th, with the first laptops shipping on January 27th — ...
With a PADI 5-Star dive and watersports center, a sandy, secluded beachfront, and one of the best restaurants on the island, ...
Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...
Elon Musk is rapidly scaling xAI’s Colossus data center into a hyperscale AI powerhouse, raising stakes around power, cost, ...
Background Hepatocellular carcinoma (HCC) is a leading cause of cancer mortality with limited therapeutic options. Despite ...